<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97343">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01770457</url>
  </required_header>
  <id_info>
    <org_study_id>B2009:130</org_study_id>
    <nct_id>NCT01770457</nct_id>
  </id_info>
  <brief_title>Cytokine Response in Septic Shock</brief_title>
  <official_title>Cytokine Response in Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to examine the early sequential cytokine responses during antibiotic
      therapy and resuscitation of septic shock in relation to clinical manifestations of disease.

      The specific objective is to obtain sequential serum samples from patients with septic
      shock, examine a broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc)
      in a rigorous manner and correlate these responses to administration of antibiotics,
      resuscitative efforts and physiologic responses to illness (temp, HR, blood pressure, WBC,
      etc).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients must be on vasopressors Patients cannot be on pressors for &gt; 24 hrs prior to
      consent
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Cytokine response in septic shock</measure>
    <time_frame>Hours 0, 3, 6, 12, 18, 24, 36, 48, 96 and day 7</time_frame>
    <safety_issue>No</safety_issue>
    <description>his study is designed to examine the early sequential cytokine responses during antibiotic therapy and resuscitation of septic shock in relation to clinical manifestations of disease.
The specific objective is to obtain sequential serum samples from patients with septic shock, examine a broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc) in a rigorous manner and correlate these responses to administration of antibiotics, resuscitative efforts and physiologic responses to illness (temp, HR, blood pressure, WBC, etc).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">325</enrollment>
  <condition>Septic Shock</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples will be collected at specific time points. Initial time point determined by
      start of Vasopressors Then sequential serum samples will be drawn from patients to examine a
      broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients with septic shock admitted to intensive care units who are  receiving
        vasopressors for septic shock for &lt;24 hrs.  No significant exclusions exist.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult ICU patients: . 18 years admitted with septic shock

          -  Receiving Vasopressors &lt; 24 hrs

        Exclusion Criteria:

          -  Consent refused by patient or SDM

          -  Received Vasopressors &gt; 24hrs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anand Kumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anand Kumar, MD</last_name>
    <phone>204-291-0372</phone>
    <email>akumar61@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wendy Janz, RN</last_name>
    <phone>204-787-1405</phone>
    <email>wjanz@hsc.mb.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Health Sciences Centre, Winnipeg</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A 1R9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Janz, RN</last_name>
      <phone>204-787-1405</phone>
      <email>wjanz@hsc.mb.ca</email>
    </contact>
    <investigator>
      <last_name>Anand Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>January 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Dr. Anand Kumar</investigator_full_name>
    <investigator_title>Attending physician/ investigator WRHA</investigator_title>
  </responsible_party>
  <keyword>ICU population</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
